title: The role of MRI in prostate cancer active surveillance.
abstract: Prostate cancer is the most common cancer diagnosis in American men, excluding skin cancer. The clinical behavior of prostate cancer varies from low-grade, slow growing tumors to high-grade aggressive tumors that may ultimately progress to metastases and cause death. Given the high incidence of men diagnosed with prostate cancer, conservative treatment strategies such as active surveillance are critical in the management of prostate cancer to reduce therapeutic complications of radiation therapy or radical prostatectomy. In this review, we will review the role of multiparametric MRI in the selection and follow-up of patients on active surveillance.
authors.affiliation: Molecular Pharmacology Section, Medical Oncology Branch, National Cancer Institute, Bethesda, MD 20852, USA.
authors.forename: Linda M
authors.initials: LM
authors.lastname: Johnson
authors.affiliation: Molecular Imaging Program, National Cancer Institute, Bethesda, MD 20852, USA.
authors.forename: Peter L
authors.initials: PL
authors.lastname: Choyke
authors.affiliation: Molecular Pharmacology Section, Medical Oncology Branch, National Cancer Institute, Bethesda, MD 20852, USA ; Clinical Pharmacology Program, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20852, USA.
authors.forename: William D
authors.initials: WD
authors.lastname: Figg
authors.affiliation: Molecular Imaging Program, National Cancer Institute, Bethesda, MD 20852, USA.
authors.forename: Baris
authors.initials: B
authors.lastname: Turkbey
mesh_terms: D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D009367:Neoplasm Staging; D011467:Prostate / Q000000981:diagnostic imaging* / Q000473:pathology; D017430:Prostate-Specific Antigen / Q000097:blood; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000097:blood / Q000000981:diagnostic imaging* / Q000601:surgery; D011859:Radiography
chemical_list: D017430:Prostate-Specific Antigen